Equity Incentive Plans, Inducement Grant and Valuation (Details)	12 Months Ended
	Dec. 31, 2024 Option $ / shares shares	Dec. 31, 2023 $ / shares shares	Dec. 31, 2022 Option shares
Number of Options [Roll Forward]
Ending balance (in shares)	2,974,219
Weighted Average Remaining Life Years [Abstract]
Weighted average remaining life years	10 years
Options Vested and Exercisable [Abstract]
Options vested and exercisable, Number of option vested (in shares)	1,308,379
Options vested and exercisable, Weighted average exercise price (in dollars per share) | $ / shares	$ 2.35
Inducement Grants [Member]
Inducement Grant [Abstract]
Number of stock option grants | Option	1		2
Vesting period	4 years
Number of Options [Roll Forward]
Beginning balance (in shares)	150,000
Granted (in shares)	100,000	100,000	150,000
Ending balance (in shares)	250,000	150,000
Weighted Average Exercise Price [Abstract]
Beginning balance (in dollars per share) | $ / shares	$ 2.42
Granted (in dollars per share) | $ / shares	1.1	$ 1.1
Ending balance (in dollars per share) | $ / shares	$ 1.89	$ 2.42
Weighted Average Remaining Life Years [Abstract]
Weighted average remaining life years	8 years 25 days	8 years 4 months 24 days
Granted	9 years 1 month 13 days
Options Vested and Exercisable [Abstract]
Options vested and exercisable, Number of option vested (in shares)	75,000
Options vested and exercisable, Weighted average exercise price (in dollars per share) | $ / shares	$ 2.42
Options vested and exercisable, Weighted average remaining life years	7 years 4 months 9 days